HLH-2004 Protocol

The HLH-2004 protocol is a medical treatment plan designed for hemophagocytic lymphohistiocytosis (HLH), a severe immune system disorder where the body overreacts and harms itself. It involves using powerful medications such as chemotherapy drugs, steroids, and immune-suppressing agents to control the excessive immune activity. The goal is to reduce inflammation, eliminate affected immune cells, and restore normal immune function. The protocol is carefully tailored based on the patient's condition and often includes supportive care like antibiotics and blood transfusions to manage complications, aiming to improve survival and long-term outcomes.